Glaucoma Screening With Artificial Intelligence - Trial NCT06012058
Access comprehensive clinical trial information for NCT06012058 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Hong Kong and is currently Recruiting. The study focuses on Glaucoma. Target enrollment is 3175 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The University of Hong Kong
Timeline & Enrollment
N/A
Aug 26, 2023
Feb 25, 2025
Primary Outcome
Diagnostic performance for detection of glaucoma
Summary
This randomized clinical trial aims to compare the diagnostic performance of two AI-enabled
 screening strategies - ROTA (RNFL optical texture analysis) assessment versus optic disc
 photography - in detecting glaucoma within a population-based sample. Secondary objectives
 are to (1) compare the diagnostic performance of ROTA AI assessment versus OCT RNFL thickness
 assessment by AI, and ROTA AI assessment versus OCT RNFL thickness assessment by trained
 graders, (2) investigate the cost-effectiveness of AI ROTA assessment for glaucoma screening,
 and (3) estimate the prevalence of glaucoma in Hong Kong.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06012058
Non-Device Trial

